Positive News SentimentPositive NewsNASDAQ:OGI Organigram Global (OGI) Stock Price, News & Analysis $0.90 -0.02 (-1.64%) Closing price 10/14/2026 04:00 PM EasternExtended Trading$0.90 -0.01 (-0.98%) As of 10/14/2026 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Organigram Global Stock (NASDAQ:OGI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Organigram Global alerts:Sign Up Key Stats Today's Range$0.90▼$0.9250-Day Range$0.90▼$1.2952-Week Range$0.85▼$2.24Volume396,240 shsAverage Volume505,624 shsMarket Capitalization$127.49 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Organigram Global Inc. is a Canadian cannabis company that produces, processes and sells cannabis products for adult-use and medical markets. The company operates cultivation and manufacturing facilities in Canada and offers dried flower, pre-rolls, vaporizers, edibles, beverages and other cannabis products. Its brand portfolio has included Edison, SHRED, Big Bag O’ Buds, Monjour and Holy Mountain. Organigram markets products through Canadian provincial and territorial distribution systems, authorized retail stores and medical channels. The company also pursues international growth through investments, partnerships and the export of cannabis-related products where permitted by applicable regulations. Organigram was established in 2013 and is headquartered in Canada. Its operations have included a major production facility in Moncton, New Brunswick, along with additional manufacturing and cultivation capabilities developed through expansion and acquisitions. The company is listed on the Nasdaq under the symbol OGI and on the Toronto Stock Exchange under the symbol OGI.AI Generated. May Contain Errors. Read More Organigram Global Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks35th Percentile Overall ScoreOGI MarketRank™: 1.749802579625 of 5 starsOrganigram Global scored higher than 35% of companies evaluated by MarketBeat, and ranked 730th out of 873 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.4 / 5Analyst RatingHold Consensus RatingOrganigram Global has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageOrganigram Global has only been the subject of 1 research reports in the past 90 days.Read more about Organigram Global's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Organigram Global are expected to grow in the coming year, from ($0.11) to $0.05 per share.Price to Book Value per Share RatioOrganigram Global has a P/B Ratio of 0.49. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Organigram Global's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.19% of the float of Organigram Global has been sold short.Short Interest Ratio / Days to CoverOrganigram Global has a short interest ratio ("days to cover") of 8.06.Change versus previous monthShort interest in Organigram Global has recently decreased by 7.77%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldOrganigram Global does not currently pay a dividend.Dividend GrowthOrganigram Global does not have a long track record of dividend growth. News and Social Media4.3 / 5News SentimentN/A News SentimentOrganigram Global has a news sentiment score of 1.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Organigram Global this week, compared to 2 articles on an average week.Search Interest3 people have searched for OGI on MarketBeat in the last 30 days. MarketBeat Follows7 people have added Organigram Global to their MarketBeat watchlist in the last 30 days. This is an increase of 600% compared to the previous 30 days. Company Ownership0.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Organigram Global insiders have not sold or bought any company stock.Percentage Held by Insiders0.09% of the stock of Organigram Global is held by insiders.Percentage Held by Institutions34.63% of the stock of Organigram Global is held by institutions.Read more about Organigram Global's insider trading history. Receive OGI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Organigram Global and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OGI Stock News HeadlinesTranscript : Organigram Global Inc. - Special CallSeptember 30, 2026 | marketscreener.comMOrganigram Global to Premiere The 2026 OG Investor Session Today at 4:00 p.m. ET on XSeptember 30, 2026 | financialpost.comFALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions. | Weiss Ratings (Ad)Organigram Global to Host 2026 OG Investor SessionSeptember 2, 2026 | financialpost.comFOrganigram Global to Host 2026 OG Investor SessionSeptember 2, 2026 | businesswire.comOrganigram Global’s Earnings Call Signals MomentumAugust 15, 2026 | tipranks.comOrganigram Global Inc.: Organigram Reports Record Third Quarter Fiscal 2026 ResultsAugust 11, 2026 | finanznachrichten.deOrganigram Reports Record Third Quarter Fiscal 2026 ResultsAugust 11, 2026 | businesswire.comSee More Headlines OGI Stock Analysis - Frequently Asked Questions How have OGI shares performed this year? Organigram Global's stock was trading at $1.68 at the beginning of 2026. Since then, OGI shares have decreased by 46.2% and is now trading at $0.9039. How were Organigram Global's earnings last quarter? Organigram Global Inc. (NASDAQ:OGI) released its earnings results on Tuesday, May, 12th. The company reported ($0.01) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.01). The firm had revenue of $42.99 million for the quarter, compared to analysts' expectations of $50.56 million. Organigram Global had a negative trailing twelve-month return on equity of 13.39% and a net margin of 28.14%. Read the conference call transcript. When did Organigram Global's stock split? Organigram Global shares reverse split on Friday, July 7th 2023.The 1-4 reverse split was announced on Friday, July 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. How do I buy shares of Organigram Global? Shares of OGI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Organigram Global own? Based on aggregate information from My MarketBeat watchlists, some other companies that Organigram Global investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Cronos Group (CRON), Tilray Brands (TLRY), NIO (NIO), NVIDIA (NVDA) and Kushco (KSHB). Company Calendar Last Earnings5/12/2026Today10/14/2026Next Earnings (Estimated)12/15/2026Fiscal Year End9/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (4m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 OGI's financial health is in the Red zone, according to TradeSmith. OGI has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolNASDAQ:OGI CIK1620737 Webwww.organigram.ca Phone(844) 644-4726FaxN/AEmployees1,139Year Founded2013Profitability EPS (Trailing Twelve Months)$0.46 Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$17.70 million Net Margins28.14% Pretax Margin26.88% Return on Equity-13.39% Return on Assets-8.67% Debt Debt-to-Equity Ratio0.04 Current Ratio2.61 Quick Ratio1.07 Sales & Book Value Annual Sales$185.07 million Price / Sales0.69 Cash FlowN/A Price / Cash FlowN/A Book Value$1.86 per share Price / Book0.49Miscellaneous Outstanding Shares141,040,000Free Float140,910,000Market Cap$127.49 million OptionableOptionable Beta1.50 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:OGI) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored100% overnight gains?Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies. Dr. Mark Sko...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Global Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organigram Global With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
